1 |
Hall, J. M., Couse, J. F. and Korach, K. S. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276, 36869-36872.
DOI
ScienceOn
|
2 |
Hempling, R. E., Wong, C., Piver, M. S., Natarajan, N. and Mettlin, C. J. 1997. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Obstet Gynecol 89, 1012-1016.
DOI
|
3 |
Howell, A. 2006. Fulvestrant ('Faslodex'): current and future role in breast cancer management. Crit Rev Oncol Hematol 57, 265-273.
DOI
|
4 |
Min, G. S. 2011. Inhibitory effects of high concentrations of estrogen, progesterone and tamoxifen on proliferation of HeLa in culture. J Life Sci 21, 1746-1751
과학기술학회마을
DOI
|
5 |
Nelson, L. R. and Bulun, S. E. 2001. Estrogen production and action. J Am Acad Dermatol 45, S116-124.
DOI
|
6 |
Osborne, C. K., Wakeling, A. and Nicholson, R. I. 2004. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90, S2-6.
DOI
|
7 |
Chen, G. G., Zeng, Q. and Tse, G. M. 2008. Estrogen and its receptors in cancer. Med Res Rev 28, 954-974.
DOI
ScienceOn
|
8 |
Purdie, D., Green, A., Bain, C., Siskind, V., Ward, B., Hacker, N., Quinn, M., Wright, G., Russell, P. and Susil, B. 1995. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 62, 678-684.
DOI
ScienceOn
|
9 |
Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K. and Leung, P. C. 2001. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22, 255-288.
|
10 |
Bai, W., Oliveros-Saunders, B., Wang, Q., Acevedo-Duncan, M. E. and Nicosia, S. V. 2000. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 36, 657-666.
DOI
|
11 |
Choi, K. C., Kang, S. K., Tai, C. J., Auersperg, N. and Leung, P. C. 2001. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinol 142, 2351-2360.
DOI
|
12 |
Cui, J., Shen, Y. and Li, R. 2013. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med 19, 197-209.
DOI
|
13 |
Cunat, S., Hoffmann, P. and Pujol, P. 2004. Estrogens and epithelial ovarian cancer. Gynecol Oncol 94, 25-32.
DOI
|
14 |
Song, R. X., Mor, G., Naftolin, F., McPherson, R. A., Song, J., Zhang, Z., Yue, W., Wang, J. and Santen, R. J. 2001. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst 93, 1714-1723.
DOI
ScienceOn
|
15 |
Robertson, C. N., Roberson, K. M., Padilla, G. M., O'Brien, E. T., Cook, J. M., Kim, C. S. and Fine, R. L. 1996. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 88, 908-917.
DOI
ScienceOn
|
16 |
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. and Chambon, P. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59, 477-487.
DOI
ScienceOn
|
17 |
Wardell, S. E., Marks, J. R. and McDonnell, D. P. 2011. The turnover of estrogen receptor by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy. Biochem Pharmacol 82, 122-130.
DOI
|
18 |
Rao, M. C., Midgley, A. R. Jr. and Richards, J. S. 1978. Hormonal regulation of ovarian cellular proliferation. Cell 14, 71-78.
DOI
ScienceOn
|
19 |
Lewis, J. S., Meeke, K., Osipo, C., Ross, E. A., Kidawi, N., Li, T., Bell, E., Chandel, N. S. and Jordan, V. C. 2005. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97, 1746-1759.
DOI
ScienceOn
|
20 |
Li, Z. B., Chen, Y. X., Zhao, J. Y. and Lu, J. 2006. Effects of pharmacological concentrations of estrogens on growth of 3AO human ovarian cancer cells. Yi Chuan Xue Bao 33, 782-792.
|
21 |
McKenna, N. J., Lanz, R. B. and O'Malley, B. W. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20, 321-344.
|
22 |
Yoo, C., Kim, S. B., Ahn, J. H., Jung, K. H., Ahn, Y., Gong, G., Kim, H. H., Kim, H. J., Son, B. H. and Ahn, S. H. 2011. Efficacy of fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer: a preliminary report. J Breast Cancer 14, 135-139.
DOI
|
23 |
Weiss, N. S., Lyon, J. L., Krishnamurthy, S., Dietert, S. E., Liff, J. M. and Daling, J. R. 1982. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 68, 95-98.
|
24 |
Wright, J. W., Stouffer, R. L. and Rodland, K. D. 2005. High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells. J Clin Endocrinol Metab 90, 3688-3695.
DOI
ScienceOn
|
25 |
Yeh, W. L., Shioda, K., Coser, K. R., Rivizzigno, D., McSweeney, K. R. and Shioda, T. 2013. Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor protein in MCF-7 cells require the CSK c-Src tyrosine kinase. PLoS One 8, e60889.
DOI
|
26 |
Robertson, J. F. 2007. Fulvestrant (Faslodex) - how to make a good drug better. Oncologist 12, 774-784.
DOI
ScienceOn
|
27 |
Saintier, D., Khanine, V., Uzan, B., Ea, H. K., de Vernejoul, M. C. and Cohen-Solal, M. E. 2006. Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. J Steroid Biochem Mol Biol 99, 165-173.
DOI
|
28 |
Seli, E., Guzeloglu-Kayisli, O., Cakmak, H., Kayisli, U. A., Selam, B. and Arici, A. 2006. Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating Fas and Fas ligand expression. J Clin Endocrinol Metab 91, 4995-5001.
DOI
|
29 |
Lee, Y., Renaud, R. A., Friedrich, T. C. and Gorski, J. 1998. Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis. J Steroid Biochem Mol Biol 67, 327-332.
DOI
|
30 |
Purdie, D. M., Bain, C. J., Siskind, V., Russell, P., Hacker, N. F., Ward, B. G., Quinn, M. A. and Green, A. C. 1999. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer 81, 559-563.
DOI
ScienceOn
|
31 |
Yaffe, K., Sawaya, G., Lieberburg, I. and Grady, D. 1998. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279, 688-695.
DOI
ScienceOn
|